On March 6, 2012, the United States District Court for the District of Maryland ruled in favor of arguments made by Hollingsworth LLP, that insurance coverage is an asset surviving bankruptcy and that Porter Hayden Company…
After just over two hours of deliberation, an 11-person jury in the Western District of Kentucky (Bowling Green), returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation following a three-week trial. In Kyle v. Novartis…
The U.S. District Court for the Eastern District of New York granted summary judgment in favor of firm client Sandoz Inc., along with APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc., Teva Parenteral Medicines, Inc., and Hospira,…
Judge P.K. Holmes of the U.S. District Court for the Western District of Arkansas granted Firm client Novartis Pharmaceuticals Corporation’s motion to dismiss in McDaniel v. Novartis Pharm. Corp., No. 2:08-cv-02088-PKH (W.D. Ark. Jan. 6, 2012)…
A Magistrate Judge in the U.S. District Court for the Eastern District of North Carolina recommended that the motion of Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey law to the issue of punitive damages be…
Judge Jessica Mayer granted the motion of defendant Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey punitive damages law in a pharmaceutical products liability lawsuit filed in New Jersey state court by a Virginia resident for…
Judge William Duffey of the U.S. District Court for the Northern District of Georgia granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation in a case alleging that plaintiff’s treatment with Novartis’s drugs Aredia…
The Mississippi Supreme Court reversed a $7 million jury verdict against Sherwin-Williams in a lead paint case, holding that the trial court erred in failing to exclude plaintiffs’ expert causation witnesses. In the Firm’s role as…
In Emerson v. Novartis Pharm. Corp., No. 09-6273, 2011 WL 3701835 (6th Cir. Aug. 23, 2011), the Sixth Circuit affirmed a grant of summary judgment based upon a statutory presumption created by Florida law. Florida has…
In 2011, the Sixth Circuit affirmed summary judgment for Novartis in three cases, in which plaintiffs had no retained experts on the subject of specific causation, i.e., did Aredia and/or Zometa cause plaintiffs to develop osteonecrosis…
The U.S. Court of Appeals for the Second Circuit affirmed summary judgment in favor of Firm client General Electric International, Inc. (“GEII”), bringing to a close a wrongful death and survival action brought against the company…
The U.S. District Court for the Western District of North Carolina granted a motion filed by Firm client Novartis Pharmaceuticals Corporation (“NPC”) to preclude punitive damages law in this case involving claims that the drugs Aredia…
Kerlinsky v. Sandoz Inc., et al. No. 09-cv-30136 (D. Mass. May 5, 2011)
Hogan v. Novartis Pharm. Corp., 1:06-cv-00260-BMC-RER (E.D.N.Y. May 3, 2011)
After two hours of deliberation, a New Brunswick, New Jersey jury returned a 7-2 verdict in favor of Novartis Pharmaceuticals Corporation in a ten-day trial involving Aredia and Zometa, bisphosphonate drugs given to people whose cancer…
